Loading clinical trials...
Loading clinical trials...
Oral Amantadine Versus IV Amantadine to Attenuate the Hemodynamic Response to Laryngoscopy, Tracheal Intubation and Surgical Incision and Their Effect on β-endorphin: A Randomized Clinical Trial
Conditions
Interventions
oral Amantadine sulfate
i.v Amantadine Sulfate
+1 more
Locations
1
Egypt
Assiut university hospitals
Asyut, Egypt
Start Date
August 15, 2018
Primary Completion Date
March 1, 2022
Completion Date
April 1, 2022
Last Updated
November 16, 2021
NCT07185074
NCT05002790
NCT03726086
NCT05439109
NCT04863846
NCT03081611
Lead Sponsor
Assiut University
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions